Nippon India Pharma Fund - Direct - Growth
A Equity Scheme by Nippon Life India Asset Management Limited
3Y Returns (CAGR)
25.51%
Expense Ratio
0.93%
as of 01/02/2026
AUM
₹2,194.54 Cr
Qtr End: Dec 25
NAV
₹574.455
as of 02/03/2026
3Y Returns (CAGR)
25.51%
Expense Ratio
0.93%
as of 01/02/2026
AUM
₹2,194.54 Cr
Qtr End: Dec 25
NAV
₹574.455
as of 02/03/2026
Historical Performance
Investment growth and SIP performance over time.
Lump Sum mode selected.
₹
Total Invested₹10.0k
Current Value₹19.6k
Abs. Returns95.7%
CAGR25.2%
Growth of ₹10.0k
Loading Chart...
Performance Metrics
Returns, CAGR, and Volatility.
| Period | Returns | CAGR | Volatility |
|---|---|---|---|
| 3M | -0.09% | -0.36% | 12.48% |
| 6M | -0.09% | -0.18% | 10.96% |
| 1Y | 10.57% | 10.57% | 13.23% |
| 3Y | 97.69% | 25.51% | 12.68% |
| 5Y | 115.25% | 16.57% | 13.26% |
Scheme Details
- Launch Date
- 10/05/2004
- Fund Age
- 21.8 years
- Minimum Investment
- ₹5,000
- Fund House
- Nippon India Mutual Fund
- Category
- Equity Scheme
- Sub-category
- Sectoral/ Thematic (Equity Scheme)
Similar Funds
Top funds in the same category and sub-category.
| Scheme | 3Y CAGR (%) | TER (%) | AUM (Cr) |
|---|---|---|---|
| Aditya Birla Sun Life International Equity Fund - Direct - Growth | 18.73% | 2.06% | ₹69.63 |
| DSP Banking & Financial Services Fund - Direct - Growth | - | 0.62% | ₹280.2 |
| SBI BANKING & FINANCIAL SERVICES FUND - Direct - Growth | 25.11% | 0.73% | ₹4,503.48 |
| Mirae Asset Banking and Financial Services Fund - Direct - Growth | 22.16% | 0.56% | ₹344.25 |
| ITI Banking and Financial Services Fund - Direct - Growth | 19.48% | 0.40% | ₹10.21 |
| WhiteOak Capital Pharma and Healthcare Fund - Direct - Growth | - | 0.67% | ₹79.26 |
| Tata Banking & Financial Services Fund - Direct - Growth | 21.35% | 0.52% | ₹899.75 |